Indication intelligence, analysis and sector perception

Happy Thanksgiving ... giving thanks and be SAFE!

November 24, 2022

Give thanks for .... unknown blessings  already on their way!   There's more...

RegMed Investors (RMi) Research Note: Applied Genetic Technologies (AGTC)

November 15, 2022

The stock is trading at $0.39.09 (+0.72% or +$0.0028) as compared to tender offer of $0.34 A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share upon the achievement of specified milestones. Investors NEED to tender; a NON vote will render the company bankrupt, liquidated and investors will get NOTHING!

RegMed Investors (RMi) research note: BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) Shut-down by FDA on New Biologics License Application (BLA) for the ALS treatment with NurOwn

November 10, 2022

BCLI is down -$1.39 or -48.09% and fluctuating BCLI has received a refusal to file letter from the U.S. Food and Drug Administration (FDA) regarding the company's New Biologics License Application (BLA) for NurOwn for the treatment of ALS. The FDA has indicated that the company can request a Type A meeting to discuss the content of the refusal to file letter.